Nemaura Medical Inc (NASDAQ:NMRD) (FRA:N18A) has re-launched its corporate website www.nemauramedical.com and the website www.beatdiabetes.life for its flagship program BEATdiabetes.
In a statement Tuesday, the UK-based company said the BEATdiabetes website serves as the unofficial launch of the program and allows users to register and learn about participating in an overall health management system to potentially reverse Type 2 diabetes.
“The launch of the BEATdiabetes program website is an important entry into the market to allow consumers to access many of the life management tools that come with the program,” said CEO Dr Faz Chowdhury.
READ: Nemaura Medical licenses Type 2 diabetes weight management mobile app
“In addition to introducing the smartphone and tablet app, which will provide users with our scientifically validated, personalized coaching driven by our digital platform, it also provides users with a portal to become among the first to access our non-invasive glucose monitor, which we expect to launch shortly,” he added.
Dr Chowdhury said the company believes that the combined use of the app with its sugarBEAT monitor has the potential to help reduce diabetes risk and even potentially reverse Type 2 diabetes with continued and dedicated use.
SugarBEAT is a patented, CE marked, needle-free CGM that is easily applied to the skin via patch. The device transmits blood glucose data to a mobile app to allow for better monitoring or treatment.
“In addition, the re-launch of our corporate website provides visitors with a more comprehensive view of our company,” he said.
“Previously, many visitors had equated one of our single products with the company in general. However, Nemaura is constantly developing its technology and already has designed multiple products that are in the process of being refined for regulatory approval and launch.”
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraham
